Literature DB >> 6140490

Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease.

T Arendt, V Bigl, F Walther, M Sonntag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6140490     DOI： 10.1016/s0140-6736(84)90116-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.

Authors:  K J Reinikainen; P J Riekkinen; L Paljärvi; H Soininen; E L Helkala; J Jolkkonen; M Laakso
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

3.  Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.

Authors:  J Sirviö; R Kutvonen; H Soininen; P Hartikainen; P J Riekkinen
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Serum and CSF cholinesterase activity in various kinds of dementia.

Authors:  A K Szilágyi; A Németh; E Martini; B Lendvai; V Venter
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

5.  Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome.

Authors:  R Crols; J Saerens; M Noppe; A Lowenthal
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

Review 6.  Cholinesterases during development of the avian nervous system.

Authors:  P G Layer
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

7.  Multiple approaches to analyse the data for rat brain acetylcholinesterase inhibition by cyclophosphamide.

Authors:  Mohammad A Kamal; M Reale; Abdulaziz A Al-Jafari
Journal:  Neurochem Res       Date:  2010-07-21       Impact factor: 3.996

8.  Acetylcholine synthesis in human CSF: implications for study of central cholinergic metabolism.

Authors:  S T DeKosky; S W Scheff; C G Hackney
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

Review 9.  Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Authors:  David G Wilkinson; Paul T Francis; Elias Schwam; Jennifer Payne-Parrish
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis.

Authors:  Mohammad A Kamal; Xianqin Qu; Qian-Sheng Yu; David Tweedie; Harold W Holloway; Yazhou Li; Yi Tan; Nigel H Greig
Journal:  J Neural Transm (Vienna)       Date:  2008-01-31       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.